Insights On CONTRACT PHARMA MANUFACTURING

  1. Drug Development Outsourcing: The Devil Is In The Details 5/29/2025

    What you need and what a CDMO can offer specifically, the nuances of your development program, and the way both sides approach the outsourcing relationship will determine a successful development path.

  2. The 3 Models Of Outsourcing 5/29/2025

    Jumai Abioye, Ph.D., Founder and CEO, Pan Access Innovations, offers her three models of outsourcing and working with CDMOs, for biotechs of all shapes and sizes.

  3. Accelerate And Enhance Biomanufacturing Operator Training 5/28/2025

    Unlock the power of blended operator training and learn how combining digital tools with hands-on instruction reduces errors, boosts retention, and empowers your workforce for real-world production success.

  4. Navigating CMC Regulation For Plasmid DNA In Gene Therapy 5/28/2025

    Explore how evolving regulatory pathways and CMC innovation are shaping the future of gene therapy and viral vector production, plus what to consider when selecting a CDMO partner.

  5. Advancing Lentiviral Vector Manufacturing: A Platform For Commercial Cell Therapy Success 5/28/2025

    Explore how the LentiPeak™ platform can accelerate the development and commercialization of LV-based therapies, using GMP manufacturing, scale-down model validation, and a process design approach.

  6. Evaluating BACS For T Cell Isolation In CAR-T Manufacturing 5/28/2025

    Consider how Buoyancy Activated Cell Sorting (BACS) can streamline T cell isolation, reduce costs, and enhance CAR T and TCR cell therapy manufacturing — access the full study to learn more.

  7. CRISPR System Enables CNS Biodistribution, mHTT Protein Reduction 5/28/2025

    Discover how a diverse collection of RNA-guided nucleases, base editors, and reverse transcriptase editors with unique PAM recognition sequences can enable flexible and precise genome editing.

  8. Driving Innovation And Scalability In Advanced Therapies 5/28/2025

    By fostering strong collaborations and maintaining flexibility, BaseCamp is preparing for the complex landscape of commercial manufacturing while prioritizing quality, efficiency, and patient access.

  9. An Extended Kinetics Study Of AAV Viral Vector Production 5/28/2025

    This study aims to explore the kinetics of capsid formation and impurity profiles over time, offering insights that can inform future process improvements.

  10. Taking A Look At AAV Production Using HEK293 In A Perfusion Process 5/28/2025

    Discover a scalable, cost-effective solution for gene therapy manufacturing with VintaProcess™ — featuring VintaCell™, VintaFect™, and fixed-bed bioreactor technology.